Day 3

The “New” Tech Commercialization Model: from TTO to Venture

April 23, 2025 8:05–8:45 AM
Strategy 2 & Strategy 3
Session Type
The “New” Tech Commercialization Model: from TTO to Venture

Moderator: Chris Sloan - Shareholder, Baker Donelson

Hear from the innovative leaders who are transforming how the “modern” university or national lab prepares their most disruptive technologies for venture capital investment. 

Speakers:

  • Blake Patton – Managing Director, Tech Square Ventures
  • Mary Albertson- Director of Technology Licensing, Georgia Institute of Technology
  • Alan Bentley – Assistant Vice Chancellor, Vanderbilt University
  • Jennifer Caldwell – Director of Technology Transfer, Oak Ridge National Laboratory
     

Showcase: Moleculera Biosciences, Inc.

April 23, 2025 9:45–10:05 AM
Strategy 1
Sectors
Session Type

Moleculera Biosciences is a precision diagnostics company pioneering clinical diagnostics services for inflammatory brain and cardiovascular disorders using an integrated business model. The company enables clinicians to accurately diagnose, treat, and monitor patients suffering from chronic immune-mediated disorders, leading to remarkable recoveries.

Key highlights include:

  • Autoimmune Brain Panel®: Generated $1.2MM in 2024 without a sales team
  • Product pipeline: Preparing to launch the Autoimmune Cardiovascular Panel™ in 2026 and the Autoimmune Alzheimer's Panel™ in 2027
  • Predictive treatment algorithm: Developing an algorithm leveraging a 16,000 clinically annotated biobank and bioinformatics repository to eliminate the trial-and-error of prescribing for these disorders
  • Biorepository potential: Leveraging the repository to identify new companion diagnostics and novel targets for therapy

Showcase: Parasight System Inc

April 23, 2025 10:10–10:30 AM
Strategy 1

Parasight System Inc. has developed and manufactures a veterinary diagnostic analyzer that combines antigen-based fluorescence detection with advanced AI-powered image recognition technology, delivering highly accurate and efficient analysis for a variety of diagnostic tests and different medium, including fecal, heartworm, and Lyme disease tests in veterinary practices.

Showcase: RIF Robotics Corp

April 23, 2025 8:55–9:15 AM
Strategy 2

At RIF Robotics, we are building PacR, a product that leverages computer vision, artificial intelligence, and robotics to streamline the inspection of surgical instruments for cleanliness and automate surgical tray assembly in hospitals and ambulatory surgery centers to eliminate surgery delays and improve patient outcomes.